Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Journal of Veterinary Internal Medicine
|
June 5, 2026
Efficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumor
Esther Chon, Mohamad Morsey, Terry Katz, et al.
BMC Veterinary Research
|
June 12, 2015
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
Heather L Gardner, Cheryl A London, Roberta A Portela, et al.
Melanoma Research
|
May 20, 2024
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma
Mark R Albertini, Cindy L Zuleger, Erik A Ranheim, et al.
Frontiers in Immunology
|
May 30, 2025
Single cell atlas of canine natural killer cells identifies distinct circulating and tissue resident gene profiles
Aryana M Razmara, Marshall Lammers, Sean J Judge, et al.
Frontiers in Immunology
|
November 10, 2025
Comparative transcriptomic analysis of tumor- infiltrating canine natural killer cells and candidate biomarkers from first-in-dog NK immunotherapy trials
Aryana M Razmara, Marshall Lammers, Sean J Judge, et al.
Journal of the American Veterinary Medical Association
|
November 23, 2024
Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs
Jenna H Burton, David M Vail, Jennifer L Willcox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma
David M Vail, Douglas H Thamm, Hans Reiser, et al.
Plos One
|
August 12, 2021
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting
Kara Magee, Ian R Marsh, Michelle M Turek, et al.
Molecular Cancer Therapeutics
|
July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
Amy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Science Translational Medicine
|
February 5, 2016
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology
Amy K LeBlanc, Matthew Breen, Peter Choyke, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Journal of Veterinary Internal Medicine
|
June 5, 2026
Efficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumor
Esther Chon, Mohamad Morsey, Terry Katz, et al.
BMC Veterinary Research
|
June 12, 2015
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
Heather L Gardner, Cheryl A London, Roberta A Portela, et al.
Melanoma Research
|
May 20, 2024
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma
Mark R Albertini, Cindy L Zuleger, Erik A Ranheim, et al.
Frontiers in Immunology
|
May 30, 2025
Single cell atlas of canine natural killer cells identifies distinct circulating and tissue resident gene profiles
Aryana M Razmara, Marshall Lammers, Sean J Judge, et al.
Frontiers in Immunology
|
November 10, 2025
Comparative transcriptomic analysis of tumor- infiltrating canine natural killer cells and candidate biomarkers from first-in-dog NK immunotherapy trials
Aryana M Razmara, Marshall Lammers, Sean J Judge, et al.
Journal of the American Veterinary Medical Association
|
November 23, 2024
Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs
Jenna H Burton, David M Vail, Jennifer L Willcox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma
David M Vail, Douglas H Thamm, Hans Reiser, et al.
Plos One
|
August 12, 2021
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting
Kara Magee, Ian R Marsh, Michelle M Turek, et al.
Molecular Cancer Therapeutics
|
July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
Amy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Science Translational Medicine
|
February 5, 2016
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology
Amy K LeBlanc, Matthew Breen, Peter Choyke, et al.
Page
of 8